Bumrungrad Hospital Public Company Limited (FRA:BZ7A)

FRA:BZ7A Statistics

Total Valuation

FRA:BZ7A has a market cap or net worth of EUR 3.64 billion. The enterprise value is 3.32 billion.

Market Cap	3.64B
Enterprise Value	3.32B

Important Dates

The next estimated earnings date is Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	Aug 14, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.04%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	2.07%
Owned by Institutions (%)	43.41%
Float	715.35M

Valuation Ratios

The trailing PE ratio is 18.44 and the forward PE ratio is 17.47.

PE Ratio	18.44
Forward PE	17.47
PS Ratio	5.46
PB Ratio	4.72
P/TBV Ratio	4.89
P/FCF Ratio	19.54
P/OCF Ratio	16.03
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.48, with an EV/FCF ratio of 17.79.

EV / Earnings	16.79
EV / Sales	4.86
EV / EBITDA	12.48
EV / EBIT	13.80
EV / FCF	17.79

Financial Position

The company has a current ratio of 4.72, with a Debt / Equity ratio of 0.00.

Current Ratio	4.72
Quick Ratio	4.57
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.02
Interest Coverage	1,244.18

Financial Efficiency

Return on equity (ROE) is 27.44% and return on invested capital (ROIC) is 20.14%.

Return on Equity (ROE)	27.44%
Return on Assets (ROA)	17.39%
Return on Invested Capital (ROIC)	20.14%
Return on Capital Employed (ROCE)	29.33%
Revenue Per Employee	205,009
Profits Per Employee	60,748
Employee Count	3,253
Asset Turnover	0.79
Inventory Turnover	40.43

Taxes

In the past 12 months, FRA:BZ7A has paid 41.78 million in taxes.

Income Tax	41.78M
Effective Tax Rate	17.36%

Stock Price Statistics

The stock price has decreased by -18.90% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-18.90%
50-Day Moving Average	4.55
200-Day Moving Average	4.38
Relative Strength Index (RSI)	40.08
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:BZ7A had revenue of EUR 666.89 million and earned 197.61 million in profits. Earnings per share was 0.23.

Revenue	666.89M
Gross Profit	346.08M
Operating Income	234.71M
Pretax Income	240.72M
Net Income	197.61M
EBITDA	258.56M
EBIT	234.71M
Earnings Per Share (EPS)	0.23

Balance Sheet

The company has 329.66 million in cash and 2.91 million in debt, giving a net cash position of 326.75 million.

Cash & Cash Equivalents	329.66M
Total Debt	2.91M
Net Cash	326.75M
Net Cash Per Share	n/a
Equity (Book Value)	771.57M
Book Value Per Share	0.96
Working Capital	346.29M

Cash Flow

In the last 12 months, operating cash flow was 227.34 million and capital expenditures -40.87 million, giving a free cash flow of 186.47 million.

Operating Cash Flow	227.34M
Capital Expenditures	-40.87M
Free Cash Flow	186.47M
FCF Per Share	n/a

Margins

Gross margin is 51.89%, with operating and profit margins of 35.19% and 29.63%.

Gross Margin	51.89%
Operating Margin	35.19%
Pretax Margin	36.10%
Profit Margin	29.63%
EBITDA Margin	38.77%
EBIT Margin	35.19%
FCF Margin	27.96%

Dividends & Yields

This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 3.05%.

Dividend Per Share	0.13
Dividend Yield	3.05%
Dividend Growth (YoY)	1.32%
Years of Dividend Growth	3
Payout Ratio	53.18%
Buyback Yield	-0.04%
Shareholder Yield	3.00%
Earnings Yield	5.42%
FCF Yield	5.12%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:BZ7A has an Altman Z-Score of 22.24 and a Piotroski F-Score of 6.

Altman Z-Score	22.24
Piotroski F-Score	6